Dr. Paul A. Kedeshian, MD

Dr. Kedeshian practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Kedeshian's NPI, 1073539060, was assigned on July 14, 2006. Dr. Kedeshian graduated from New York University School of Medicine in 1992. Dr. Kedeshian holds California license G79315.

Dr. Kedeshian's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Kedeshian's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Kedeshian is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Head & Neck Associates. Dmand AI also links Dr. Kedeshian to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kedeshian practices, 5 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Kedeshian's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Kedeshian is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Kedeshian's licenses on file in 2 states: California and New York.

Dmand AI lists chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, endoscopic sinus surgery, larynx and vocal cord disease and upper respiratory infection (URI) among the conditions Dr. Kedeshian treats.

CMS data shows 894 Medicare services from Dr. Kedeshian across 9 procedure codes in 2024, for 265 Medicare patients. Medicare paid $132,728 for them. Every service was in an office.

CMS counts 265 Medicare patients who saw Dr. Kedeshian in 2024. The largest group is 65 to 74, with 114 patients. 75% of them have high cholesterol, and 67% have high blood pressure. 28% are also on Medicaid. Their average risk score is 1.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kedeshian's median patient age at 57, with 51% women.

In 2024, Dr. Kedeshian wrote 161 Medicare Part D claims for 69 patients. 98% of them were for generic drugs. CMS names the drug for 96 of them, across 5 drugs with 11 or more claims each, at $1,079 in total drug cost. In 2023, CMS named 43 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Kedeshian for performance year 2024, reported as part of a group. Dr. Kedeshian accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 14 general payments to Dr. Kedeshian from 7 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. PolyNovo North America LLC paid the most, $147.

Dmand AI lists 3 awards for Dr. Kedeshian.

Dr. Kedeshian graduated from New York University School of Medicine in 1992. Dr. Kedeshian is a member of NHS.

Dr. Kedeshian is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.